BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35018427)

  • 1. Patients' openness to discussing implantable cardioverter defibrillator deactivation at end of life: a cross-sectional study.
    Lee KS; Oh O; Miller J; Hammash M; Thompson DR; Ski CF; Cameron J; Hwang SY; Moser DK
    Eur J Cardiovasc Nurs; 2022 Oct; 21(7):687-693. PubMed ID: 35018427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octo- and nonagenarians' outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study.
    Thylén I; Moser DK; Strömberg A
    BMC Geriatr; 2018 Oct; 18(1):250. PubMed ID: 30342484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.
    Hill L; McIlfatrick S; Taylor B; Dixon L; Harbinson M; Fitzsimons D
    Palliat Med; 2015 Apr; 29(4):310-23. PubMed ID: 25239128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICD recipients' understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life.
    Strömberg A; Fluur C; Miller J; Chung ML; Moser DK; Thylén I
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):834-42. PubMed ID: 24483943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillator (ICD) deactivation discussions: Reality versus recommendations.
    Hill L; McIlfatrick S; Taylor BJ; Dixon L; Cole BR; Moser DK; Fitzsimons D
    Eur J Cardiovasc Nurs; 2016 Feb; 15(1):20-9. PubMed ID: 25903823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared Decision-Making About End-of-Life Care Scenarios Compared Among Implantable Cardioverter Defibrillator Patients: A National Cohort Study.
    Thompson JH; Thylén I; Moser DK
    Circ Heart Fail; 2019 Oct; 12(10):e005619. PubMed ID: 31601115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life.
    Pedersen SS; Chaitsing R; Szili-Torok T; Jordaens L; Theuns DA
    Am J Cardiol; 2013 May; 111(10):1443-7. PubMed ID: 23490027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.
    Kelley AS; Reid MC; Miller DH; Fins JJ; Lachs MS
    Am Heart J; 2009 Apr; 157(4):702-8.e1. PubMed ID: 19332199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
    Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
    Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter defibrillator (ICD) functionality: patient and family information for advanced decision-making.
    Hill LM; McIlfatrick S; Taylor B; Dixon L; Fitzsimons D
    BMJ Support Palliat Care; 2022 Jul; 12(e2):e219-e225. PubMed ID: 31771959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.
    Lee MC; Sulmasy DP; Gallo J; Kub J; Hughes MT; Russell S; Kellogg A; Owens SG; Terry P; Nolan MT
    Am J Hosp Palliat Care; 2017 Jul; 34(6):518-523. PubMed ID: 27034436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Russo JE
    Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'You can't start a car when there's no petrol left': a qualitative study of patient, family and clinician perspectives on implantable cardioverter defibrillator deactivation.
    Standing H; Thomson RG; Flynn D; Hughes J; Joyce K; Lobban T; Lord S; Matlock DD; McComb JM; Paes P; Wilkinson C; Exley C
    BMJ Open; 2021 Jul; 11(7):e048024. PubMed ID: 34230020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; Theuns DA; Bhagwandien RE; van Bruchem-Visser RL; Lokker IE; van der Heide A; Rietjens JA
    Eur J Cardiovasc Nurs; 2019 Aug; 18(6):449-457. PubMed ID: 30995145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
    Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.
    Herman M; Horner K; Ly J; Vayl Y
    J Hosp Palliat Nurs; 2018 Feb; 20(1):63-71. PubMed ID: 30063615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives.
    Lewis KB; Stacey D; Matlock DD
    Patient; 2014; 7(3):243-60. PubMed ID: 24668214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: how much do patients want to know?
    Raphael CE; Koa-Wing M; Stain N; Wright I; Francis DP; Kanagaratnam P
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1628-33. PubMed ID: 21955046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missed opportunities! End of life decision making and discussions in implantable cardioverter defibrillator recipients.
    Miller JL; Chung ML; Etaee F; Hammash M; Thylén I; Biddle MJ; Elayi SC; Czarapata MM; McEvedy S; Cameron J; Haedtke CA; Ski CF; Thompson DR; Moser DK
    Heart Lung; 2019; 48(4):313-319. PubMed ID: 31076180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.